Boston Cell Standards

📍 Boston, United States👥 14 employees💰 Last funded Dec 2020
Medical Equipment Manufacturing🌐 bostoncellstandards.com
Website LinkedIn
Boston Cell Standards developed the world’s first calibrators and controls for immunohistochemistry testing, introducing standardized units of measure (molecules per cell) linked with an international standard (NIST SRM 1934). This breakthrough opens new opportunities for improved disease understanding, diagnosis, and treatment. In the clinical environment, our IHControls are being used in place of traditional control tissue. Our IHCalibrators are being used for new assay work-up, calibration of instrumentation, and as part of a QA/QC process to track day-to-day variabilities. In the pharma/life science arenas, BCS products are being used by primary investigators in early-stage drug development (in lieu of costly commercial controls) and by CROs at the onset of clinical trials (to ensure instrument and assay accuracy), to name a few uses. Interested in learning more? Contact us through our online form: http://bostoncellstandards.com/contact-us/
1
Total investors
0
Early stage
0
Mid stage
0
Late stage
—
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in Boston Cell Standards?
Boston Cell Standards has 1 investors on record on gritt.io.
When did Boston Cell Standards last raise funding?
The most recent investment in Boston Cell Standards recorded on gritt.io was in December 2020.
What industry is Boston Cell Standards in?
Boston Cell Standards operates in Medical Equipment Manufacturing. Find similar Medical Equipment Manufacturing investors on gritt.io.
Where is Boston Cell Standards based?
Boston Cell Standards is headquartered in Boston, United States.